Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 20 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

25%

5 trials in Phase 3/4

Results Transparency

13%

1 of 8 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (2)
P 1 (1)
P 3 (2)
P 4 (3)

Trial Status

Completed8
Recruiting5
Unknown3
Enrolling By Invitation2
Not Yet Recruiting2

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 8 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07569055RecruitingPrimary

Longitudinal Cohort Study on Invasive Fungal Disease After Allogeneic Hematopoietic Stem Cell Transplantation

NCT07559032Not ApplicableNot Yet RecruitingPrimary

Amphotericin B for Breakthrough Fungal Infections After Triazole Prophylaxis in Hematological Patients

NCT04368559Phase 3Completed

Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation

NCT03774316CompletedPrimary

De-escalation - Antifungal Treatment Immunocompromised Patients

NCT06285188RecruitingPrimary

Immunomonitoring of Mold Invasive Infections

NCT01916057Not ApplicableCompletedPrimary

Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis

NCT07135778RecruitingPrimary

Liposomal Amphotericin B and Isavuconazole/Posaconazole in Br-IFD( Breakthrough Invasive Fungal Disease) in Patients With Malignant Hematological Diseases

NCT05630976Phase 4CompletedPrimary

Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi

NCT06640296Enrolling By Invitation

L-AmB_ Retrospective mUlticenter Study on Mycosis prOphylaxis

NCT06819410RecruitingPrimary

Efficacy and Safety of Amphotericin B and Azoles in the Treatment of Invasive Fungal Disease

NCT06698211Enrolling By InvitationPrimary

Posaconazole Tablet As Primary Prophylaxis of HSCT Patients with Gastrointestinal GVHD

NCT06654076CompletedPrimary

Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant Recipients

NCT06376201Phase 4Not Yet RecruitingPrimary

A Clinical Study on the Efficacy and Safety of ABCD in the Treatment of Patients With Invasive Fungal Disease

NCT01731353RecruitingPrimary

FungiScope - A Global Emerging Fungal Infection Registry

NCT05116059UnknownPrimary

To Evaluate the Efficacy and Safety of ABCD in the Treatment of IFD

NCT05569824Unknown

LFD of Aspergillus Antigen in Paediatrics

NCT03262584CompletedPrimary

Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients

NCT03577509Phase 1CompletedPrimary

Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China

NCT01259713Phase 3CompletedPrimary

Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia

NCT01135589Phase 4Unknown

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Showing all 20 trials

Research Network

Activity Timeline